Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
3.850
0.00 (0.00%)
Jul 31, 2026, 4:00 PM EDT - Market closed
Whitehawk Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 34.79 | 37.57 | 28.67 | 62.89 | 39.02 | 148.99 |
Short-Term Investments | 88.25 | 108.13 | 18.57 | 45.96 | 133.54 | - |
Cash & Short-Term Investments | 123.04 | 145.7 | 47.24 | 108.85 | 172.56 | 148.99 |
Cash Growth | -46.75% | 208.44% | -56.60% | -36.92% | 15.82% | 3244.31% |
Accounts Receivable | - | - | 5.9 | 5.49 | 1.86 | - |
Inventory | - | - | 5.31 | 6.43 | 1.86 | - |
Other Current Assets | 2.51 | 3.32 | 2.84 | 3.83 | 3.75 | 2.28 |
Total Current Assets | 125.55 | 149.01 | 61.29 | 124.59 | 180.03 | 151.27 |
Net Property, Plant & Equipment | 0 | 0 | 7.63 | 5.97 | 2.03 | 0.61 |
Other Intangible Assets | - | - | - | - | - | 3.81 |
Other Long-Term Assets | 1.68 | 1.81 | 1.4 | 1.87 | 2.18 | 2.21 |
Total Assets | 127.23 | 150.83 | 70.32 | 132.42 | 184.24 | 157.91 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1.75 | 0.92 | 2.16 | 5.9 | 3.52 | 6.44 |
Accrued Expenses | 9.31 | 13.6 | 14.65 | 14.31 | 14.92 | 8.7 |
Current Portion of Leases | - | - | 0.27 | 0.43 | 0.39 | 0.13 |
Other Current Liabilities | - | - | - | 5.76 | - | - |
Total Current Liabilities | 11.06 | 14.52 | 17.07 | 26.4 | 18.84 | 15.27 |
Long-Term Leases | - | - | 0.57 | 0.83 | 1.27 | 0.47 |
Other Long-Term Liabilities | - | - | 0.2 | - | 5.76 | 5.76 |
Total Long-Term Liabilities | - | - | 0.77 | 0.83 | 7.02 | 6.23 |
Total Liabilities | 11.06 | 14.52 | 17.84 | 27.23 | 25.86 | 21.5 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0 | 0 | 0 | 0 | 0 | 0 |
Additional Paid-in Capital | 491.63 | 489.44 | 385.11 | 374.13 | 361.69 | 279.09 |
Accumulated Other Comprehensive Income | -0.02 | 0.12 | 0.02 | 0.03 | -0.12 | - |
Retained Earnings | -375.44 | -353.25 | -332.65 | -268.96 | -203.2 | -142.69 |
Shareholders' Equity | 116.18 | 136.31 | 52.48 | 105.2 | 158.38 | 136.41 |
Total Liabilities & Equity | 127.23 | 150.83 | 70.32 | 132.42 | 184.24 | 157.91 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | - | 0 | 0.83 | 1.27 | 1.66 | 0.61 |
Net Cash (Debt) | 123.04 | 145.7 | 46.4 | 107.58 | 170.9 | 148.38 |
Net Cash Growth | -46.75% | 213.97% | -56.87% | -37.05% | 15.17% | 3326.88% |
Net Cash Per Share | 1.78 | 2.35 | 1.72 | 4.00 | 7.59 | 16.63 |
Book Value | 116.18 | 136.31 | 52.48 | 105.2 | 158.38 | 136.41 |
Book Value Per Share | 1.68 | 2.20 | 1.94 | 3.91 | 7.04 | 15.29 |
Tangible Book Value | 116.18 | 136.31 | 52.48 | 105.2 | 158.38 | 132.6 |
Tangible Book Value Per Share | 1.68 | 2.20 | 1.94 | 3.91 | 7.04 | 14.86 |